BPC-157, a synthetically produced penta-decapeptide, a fragment of the Body Protective Compound (BPC), protein that was discovered and derived from human gastric juice, represents a sequence of 15 amino acids similar to that present in human BPC. In several research studies in animals and cultured cells, this peptide has been shown to accelerate the healing of different kinds of wounds in tissues, including tendons, muscles, joints, ligaments and has also positive effects on inflammatory bowel disorders, gut problems, ulcers, skin or even nervous system and vascular grows. Thus, this peptide can increase and accelerate blood flow in the area of injuries, which is normally very slow, it is very efficient in enhancing healing processes.

Semax belongs to the research peptides, and it is produced synthetically as a derivate of adrenocorticotropic hormone (ACTH). It has shown promise as a cognitive enhancer and potent neuroprotectant. Similarly to Selank, it was developed at the Institute of Molecular Genetics in Russia in the 1980s, and has nootropic, neuroprotective, and neurorestorative properties. Semax is used for the treatment of acute cerebral hypoxia, such as stroke or traumatic brain injury, memory and cognitive disorders, or as immunity booster. Additionally, Semax is also being studied as a possible treatment for depression, ADHD or Alzheimer’s disease.